Eintrag weiter verarbeiten
SU‐E‐T‐449: In‐Vivo Dosimetry and Range Verification for Proton Therapy
Gespeichert in:
| Zeitschriftentitel: | Medical Physics |
|---|---|
| Personen und Körperschaften: | |
| In: | Medical Physics, 40, 2013, 6Part17, S. 308-308 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
Zheng, Y Zheng, Y |
|---|---|
| author |
Zheng, Y |
| spellingShingle |
Zheng, Y Medical Physics SU‐E‐T‐449: In‐Vivo Dosimetry and Range Verification for Proton Therapy General Medicine |
| author_sort |
zheng, y |
| spelling |
Zheng, Y 0094-2405 2473-4209 Wiley General Medicine http://dx.doi.org/10.1118/1.4814882 <jats:p><jats:bold>Purpose:</jats:bold> Accurate calculation of proton dose and penetration range is critical in proton therapy. However, in‐vivo studies on dose and range verification are very limited, and there is no consensus on the appropriate amount of range uncertainty. The purpose of this study is to verify the proton dose and range and evaluate the range uncertainty using in‐vivo measurement of patients under proton therapy. <jats:bold>Methods:</jats:bold> Gafchromic EBT2 films were used in the study. The film was calibrated using proton beams, and its energy dependence was measured for various proton energy beams. Water phantom and animal tissues were first used to test the application of EBT2 on dose and range verification before the in‐vivo dosimetry study. Several patients, such as lung and brain cases, were carefully selected for in‐vivo film measurement. For example, we measured a lung case with tumor located posterior, and the EBT2 film was placed immediately under the patient to measure the dose in the distal falloff region from an anterior‐posterior beam. The measured plane dose was compared to the calculated dose from the treatment plan, which was created using the XiO treatment planning system (TPS). The dose difference at the distal falloff region was used to evaluate the range difference between measurement and planning. <jats:bold>Results:</jats:bold> The EBT2 film showed a minimal energy dependence and was able to measure proton range accurately, within 1 mm in a phantom setting. Preliminary data for a lung treatment indicate a less than 3 mm range difference between EBT2‐measured range and the TPS‐calculated one. More studies for various disease sites are in progress. <jats:bold>Conclusions:</jats:bold> Our animal tissue and in‐vivo study shows that the measured and calculated proton ranges are within 2% plus 2 mm for most cases. Further in‐vivo studies are needed to confirm our findings and evaluate range uncertainties at different facilities.</jats:p> SU‐E‐T‐449: In‐Vivo Dosimetry and Range Verification for Proton Therapy Medical Physics |
| doi_str_mv |
10.1118/1.4814882 |
| facet_avail |
Online |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExOC8xLjQ4MTQ4ODI |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExOC8xLjQ4MTQ4ODI |
| institution |
DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 |
| imprint |
Wiley, 2013 |
| imprint_str_mv |
Wiley, 2013 |
| issn |
0094-2405 2473-4209 |
| issn_str_mv |
0094-2405 2473-4209 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
zheng2013suet449invivodosimetryandrangeverificationforprotontherapy |
| publishDateSort |
2013 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
Medical Physics |
| source_id |
49 |
| title |
SU‐E‐T‐449: In‐Vivo Dosimetry and Range Verification for Proton Therapy |
| title_unstemmed |
SU‐E‐T‐449: In‐Vivo Dosimetry and Range Verification for Proton Therapy |
| title_full |
SU‐E‐T‐449: In‐Vivo Dosimetry and Range Verification for Proton Therapy |
| title_fullStr |
SU‐E‐T‐449: In‐Vivo Dosimetry and Range Verification for Proton Therapy |
| title_full_unstemmed |
SU‐E‐T‐449: In‐Vivo Dosimetry and Range Verification for Proton Therapy |
| title_short |
SU‐E‐T‐449: In‐Vivo Dosimetry and Range Verification for Proton Therapy |
| title_sort |
su‐e‐t‐449: in‐vivo dosimetry and range verification for proton therapy |
| topic |
General Medicine |
| url |
http://dx.doi.org/10.1118/1.4814882 |
| publishDate |
2013 |
| physical |
308-308 |
| description |
<jats:p><jats:bold>Purpose:</jats:bold> Accurate calculation of proton dose and penetration range is critical in proton therapy. However, in‐vivo studies on dose and range verification are very limited, and there is no consensus on the appropriate amount of range uncertainty. The purpose of this study is to verify the proton dose and range and evaluate the range uncertainty using in‐vivo measurement of patients under proton therapy. <jats:bold>Methods:</jats:bold> Gafchromic EBT2 films were used in the study. The film was calibrated using proton beams, and its energy dependence was measured for various proton energy beams. Water phantom and animal tissues were first used to test the application of EBT2 on dose and range verification before the in‐vivo dosimetry study. Several patients, such as lung and brain cases, were carefully selected for in‐vivo film measurement. For example, we measured a lung case with tumor located posterior, and the EBT2 film was placed immediately under the patient to measure the dose in the distal falloff region from an anterior‐posterior beam. The measured plane dose was compared to the calculated dose from the treatment plan, which was created using the XiO treatment planning system (TPS). The dose difference at the distal falloff region was used to evaluate the range difference between measurement and planning. <jats:bold>Results:</jats:bold> The EBT2 film showed a minimal energy dependence and was able to measure proton range accurately, within 1 mm in a phantom setting. Preliminary data for a lung treatment indicate a less than 3 mm range difference between EBT2‐measured range and the TPS‐calculated one. More studies for various disease sites are in progress. <jats:bold>Conclusions:</jats:bold> Our animal tissue and in‐vivo study shows that the measured and calculated proton ranges are within 2% plus 2 mm for most cases. Further in‐vivo studies are needed to confirm our findings and evaluate range uncertainties at different facilities.</jats:p> |
| container_issue |
6Part17 |
| container_start_page |
308 |
| container_title |
Medical Physics |
| container_volume |
40 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792335021471694851 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T14:37:37.389Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=SU%E2%80%90E%E2%80%90T%E2%80%90449%3A+In%E2%80%90Vivo+Dosimetry+and+Range+Verification+for+Proton+Therapy&rft.date=2013-06-01&genre=article&issn=2473-4209&volume=40&issue=6Part17&spage=308&epage=308&pages=308-308&jtitle=Medical+Physics&atitle=SU%E2%80%90E%E2%80%90T%E2%80%90449%3A+In%E2%80%90Vivo+Dosimetry+and+Range+Verification+for+Proton+Therapy&aulast=Zheng&aufirst=Y&rft_id=info%3Adoi%2F10.1118%2F1.4814882&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792335021471694851 |
| author | Zheng, Y |
| author_facet | Zheng, Y, Zheng, Y |
| author_sort | zheng, y |
| container_issue | 6Part17 |
| container_start_page | 308 |
| container_title | Medical Physics |
| container_volume | 40 |
| description | <jats:p><jats:bold>Purpose:</jats:bold> Accurate calculation of proton dose and penetration range is critical in proton therapy. However, in‐vivo studies on dose and range verification are very limited, and there is no consensus on the appropriate amount of range uncertainty. The purpose of this study is to verify the proton dose and range and evaluate the range uncertainty using in‐vivo measurement of patients under proton therapy. <jats:bold>Methods:</jats:bold> Gafchromic EBT2 films were used in the study. The film was calibrated using proton beams, and its energy dependence was measured for various proton energy beams. Water phantom and animal tissues were first used to test the application of EBT2 on dose and range verification before the in‐vivo dosimetry study. Several patients, such as lung and brain cases, were carefully selected for in‐vivo film measurement. For example, we measured a lung case with tumor located posterior, and the EBT2 film was placed immediately under the patient to measure the dose in the distal falloff region from an anterior‐posterior beam. The measured plane dose was compared to the calculated dose from the treatment plan, which was created using the XiO treatment planning system (TPS). The dose difference at the distal falloff region was used to evaluate the range difference between measurement and planning. <jats:bold>Results:</jats:bold> The EBT2 film showed a minimal energy dependence and was able to measure proton range accurately, within 1 mm in a phantom setting. Preliminary data for a lung treatment indicate a less than 3 mm range difference between EBT2‐measured range and the TPS‐calculated one. More studies for various disease sites are in progress. <jats:bold>Conclusions:</jats:bold> Our animal tissue and in‐vivo study shows that the measured and calculated proton ranges are within 2% plus 2 mm for most cases. Further in‐vivo studies are needed to confirm our findings and evaluate range uncertainties at different facilities.</jats:p> |
| doi_str_mv | 10.1118/1.4814882 |
| facet_avail | Online |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExOC8xLjQ4MTQ4ODI |
| imprint | Wiley, 2013 |
| imprint_str_mv | Wiley, 2013 |
| institution | DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1 |
| issn | 0094-2405, 2473-4209 |
| issn_str_mv | 0094-2405, 2473-4209 |
| language | English |
| last_indexed | 2024-03-01T14:37:37.389Z |
| match_str | zheng2013suet449invivodosimetryandrangeverificationforprotontherapy |
| mega_collection | Wiley (CrossRef) |
| physical | 308-308 |
| publishDate | 2013 |
| publishDateSort | 2013 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | Medical Physics |
| source_id | 49 |
| spelling | Zheng, Y 0094-2405 2473-4209 Wiley General Medicine http://dx.doi.org/10.1118/1.4814882 <jats:p><jats:bold>Purpose:</jats:bold> Accurate calculation of proton dose and penetration range is critical in proton therapy. However, in‐vivo studies on dose and range verification are very limited, and there is no consensus on the appropriate amount of range uncertainty. The purpose of this study is to verify the proton dose and range and evaluate the range uncertainty using in‐vivo measurement of patients under proton therapy. <jats:bold>Methods:</jats:bold> Gafchromic EBT2 films were used in the study. The film was calibrated using proton beams, and its energy dependence was measured for various proton energy beams. Water phantom and animal tissues were first used to test the application of EBT2 on dose and range verification before the in‐vivo dosimetry study. Several patients, such as lung and brain cases, were carefully selected for in‐vivo film measurement. For example, we measured a lung case with tumor located posterior, and the EBT2 film was placed immediately under the patient to measure the dose in the distal falloff region from an anterior‐posterior beam. The measured plane dose was compared to the calculated dose from the treatment plan, which was created using the XiO treatment planning system (TPS). The dose difference at the distal falloff region was used to evaluate the range difference between measurement and planning. <jats:bold>Results:</jats:bold> The EBT2 film showed a minimal energy dependence and was able to measure proton range accurately, within 1 mm in a phantom setting. Preliminary data for a lung treatment indicate a less than 3 mm range difference between EBT2‐measured range and the TPS‐calculated one. More studies for various disease sites are in progress. <jats:bold>Conclusions:</jats:bold> Our animal tissue and in‐vivo study shows that the measured and calculated proton ranges are within 2% plus 2 mm for most cases. Further in‐vivo studies are needed to confirm our findings and evaluate range uncertainties at different facilities.</jats:p> SU‐E‐T‐449: In‐Vivo Dosimetry and Range Verification for Proton Therapy Medical Physics |
| spellingShingle | Zheng, Y, Medical Physics, SU‐E‐T‐449: In‐Vivo Dosimetry and Range Verification for Proton Therapy, General Medicine |
| title | SU‐E‐T‐449: In‐Vivo Dosimetry and Range Verification for Proton Therapy |
| title_full | SU‐E‐T‐449: In‐Vivo Dosimetry and Range Verification for Proton Therapy |
| title_fullStr | SU‐E‐T‐449: In‐Vivo Dosimetry and Range Verification for Proton Therapy |
| title_full_unstemmed | SU‐E‐T‐449: In‐Vivo Dosimetry and Range Verification for Proton Therapy |
| title_short | SU‐E‐T‐449: In‐Vivo Dosimetry and Range Verification for Proton Therapy |
| title_sort | su‐e‐t‐449: in‐vivo dosimetry and range verification for proton therapy |
| title_unstemmed | SU‐E‐T‐449: In‐Vivo Dosimetry and Range Verification for Proton Therapy |
| topic | General Medicine |
| url | http://dx.doi.org/10.1118/1.4814882 |